The World Health Organization is an agency that surveys the public health at a global level. The organization has just released a new report that reveals a concerning situation. Even though there are efficient treatments, fatal cases of viral hepatitis continue to increase in number.
Viral Hepatitis Infected 4% of Global Population
The latest research paper is called Global Hepatitis Report, and it handles two main subjects. First of all, scientists collected data recorded in the year of 2015 to determine the extent to which viral hepatitis impacts worldwide nations. Secondly, the paper drew a strategic plan to stop this condition from representing a public health threat anymore by the year of 2030.
According to the findings of the report, there are 325 million cases of viral hepatitis. This amount represents 4% of the global population which is a concerning fact. Moreover, scientists recorded each year a number of 1.34 million of casualties because of it. This rate positions the ailment at the same level with other worrying diseases such as tuberculosis, HIV, and malaria. However, unlike these worldwide illnesses, viral hepatitis shows no sign of losing power. On the contrary, it continues to earn influence. Since 2000, deadly cases increased by 22% because of it.
Newborn Vaccination for Hepatitis B Was One of the Most Efficient Measures
Nonetheless, WHO created the paper as the first ever report that documented the status of such condition on a worldwide level. The research provides clear data about the current situation together with the necessary steps to curb this health threat. For instance, authorities need to decrease the number of fatal cases triggered by hepatitis from 1.34 million to up to 469,000 cases a year. This is the only way to the illness to lose its power as a public health threat.
On the other hand, there is some good news as well. According to the report, hepatitis B and C are causing 96% of fatal cases. However, there are less new infections. This is thanks to the fact that many countries adopted newborn vaccination for hepatitis B. In 2015, 84% of infants received all three doses of vaccine which is the recommended norm.
However, hepatitis C has not yet a vaccine of its own. On the other hand, authorities managed to keep treatments at an affordable level which can be even up to $200. Thanks to this report, authorities are informed on the weaknesses of the system and the needed steps to eradicate this public health threat.
Image source: 1